Clinical Trial Update: Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) [Phase 4]

View source ↗

Summary

This clinical trial update notes that the Phase 4 TAP/DAP study evaluating treatment of agitation and psychosis in dementia/parkinsonism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Parkinson Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Dementia, Parkinson Disease | Phase 4 | Status: COMPLETED